TY - JOUR
T1 - The tumor microenvironment-dependent transcription factors ahr and hif-1α are dispensable for leukemogenesis in the eµ-tcl1 mouse model of chronic lymphocytic leukemia
AU - Gonder, Susanne
AU - Largeot, Anne
AU - Gargiulo, Ernesto
AU - Pierson, Sandrine
AU - Botana, Iria Fernandez
AU - Pagano, Giulia
AU - Paggetti, Jerome
AU - Moussay, Etienne
N1 - Funding Information:
Funding: This work was supported by grants from FNRS “Télévie” to S.G., A.L., I.F.B. and G.P. (7.4502.19, 7.4503.19, 7.4529.19, 7.6518.20), from Fonds National de la Recherche Luxembourg to E.G., S.P., J.P, and E.M. (PRIDE15/10675146/CANBIO, C20/BM/14592342, and C20/BM/14582635).
Funding Information:
This work was supported by grants from FNRS ?T?l?vie? to S.G., A.L., I.F.B. and G.P. (7.4502.19, 7.4503.19, 7.4529.19, 7.6518.20), from Fonds National de la Recherche Luxembourg to E.G., S.P., J.P, and E.M. (PRIDE15/10675146/CANBIO, C20/BM/14592342, and C20/BM/14582635).We thank Carlo Croce and John Byrd (OSU, OH) for the kind gift of E?-TCL1 mouse.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/9/8
Y1 - 2021/9/8
N2 - Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in the elderly and is characterized by the accumulation of mature B lymphocytes in peripheral blood and primary lymphoid organs. In order to proliferate, leukemic cells are highly dependent on complex interactions with their microenvironment in proliferative niches. Not only soluble factors and BCR stimulation are important for their survival and proliferation, but also the activation of transcription factors through different signaling pathways. The aryl hydrocarbon receptor (AHR) and hypoxia-inducible factor (HIF)-1α are two transcription factors crucial for cancer development, whose activities are dependent on tumor microenvironment conditions, such as the presence of metabolites from the tryptophan pathway and hypoxia, respectively. In this study, we addressed the potential role of AHR and HIF-1α in chronic lymphocytic leukemia (CLL) development in vivo. To this end, we crossed the CLL mouse model Eµ-TCL1 with the corresponding transcription factor-conditional knock-out mice to delete one or both transcription factors in CD19+ B cells only. Despite AHR and HIF-1α being activated in CLL cells, deletion of either or both of them had no impact on CLL progression or survival in vivo, suggesting that these transcription factors are not crucial for leukemogenesis in CLL.
AB - Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in the elderly and is characterized by the accumulation of mature B lymphocytes in peripheral blood and primary lymphoid organs. In order to proliferate, leukemic cells are highly dependent on complex interactions with their microenvironment in proliferative niches. Not only soluble factors and BCR stimulation are important for their survival and proliferation, but also the activation of transcription factors through different signaling pathways. The aryl hydrocarbon receptor (AHR) and hypoxia-inducible factor (HIF)-1α are two transcription factors crucial for cancer development, whose activities are dependent on tumor microenvironment conditions, such as the presence of metabolites from the tryptophan pathway and hypoxia, respectively. In this study, we addressed the potential role of AHR and HIF-1α in chronic lymphocytic leukemia (CLL) development in vivo. To this end, we crossed the CLL mouse model Eµ-TCL1 with the corresponding transcription factor-conditional knock-out mice to delete one or both transcription factors in CD19+ B cells only. Despite AHR and HIF-1α being activated in CLL cells, deletion of either or both of them had no impact on CLL progression or survival in vivo, suggesting that these transcription factors are not crucial for leukemogenesis in CLL.
KW - AHR
KW - Chronic lymphocytic leukemia
KW - HIF1α
KW - Tumor microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85114347171&partnerID=8YFLogxK
UR - https://www.ncbi.nlm.nih.gov/pubmed/34572746
U2 - 10.3390/cancers13184518
DO - 10.3390/cancers13184518
M3 - Article
C2 - 34572746
AN - SCOPUS:85114347171
SN - 2072-6694
VL - 13
JO - Cancers
JF - Cancers
IS - 18
M1 - 4518
ER -